Marksans Pharma Share Price

ABOUT Marksans Pharma

• Industry Biotechnology & Drugs
• ISIN INE750C01026
• BSE Code 524404
• NSE Code MARKSANS

Marksans Pharma Limited is an India-based company, which is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two research and development centers, one located in Goa and the other in Navi Mumbai. The Company's product portfolio spreads various therapeutic segments of the cardiovascular system (CVS), central nervous system (CNS), antidiabetic, pain management, cough and cold, gastroenterological, and anti-allergies. Its product portfolio includes tablets (plain, enteric-coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. Its consumer self-care products (over-the-counter) include pain management, upper respiratory, digestive health, vitamins, minerals and supplements (VMS) and skin care products. Its prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic.

MANAGEMENT

• Mark Saldanha Executive Chairman of the Board, Managing Director
• Jitendra Sharma Group Chief Financial Officer
• Harshavardhan Panigrahi Company Secretary, Compliance Officer
• Sathish Kumar Managing Director - UK Operations
• David Mohammed Managing Director - Australia Operations
• Varddhman Jain Whole Time Director
• Sandra Saldanha Whole Time Director
• Anjani Kumar Chief Operating Officer - US Operations